Portable, cloud-connected reader for point-of-care diagnostics solutions

LumiraDx is developing point-of-care diagnostic solutions on a portable, cloud-connected reader that uses finger-prick blood samples tested on disposable, microfluidic strips. The foundation’s support is helping the company develop global health diagnostic tests on its platform and accelerate access to these and other tests for patients in low-income countries.
  • Domain
  • Investment type
    Direct equity
  • Status
  • Initial investment
    Series B
  • Partnered in
  • Investment lead
    David Rossow
  • Headquarters
    United Kingdom
  • Program strategy

More about our work

Our focus

Our six domains of focus comprise 40+ program strategies across the Foundation’s nearly $9B annual charitable support.

Investment approach

Fostering partnerships with the private sector to leverage groundbreaking global innovations for societal good.

Our team

We bring depth of experience to every investment, with a proven track record across sectors and scale.